O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
-7.79%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$5.22B
AUM Growth
+$5.22B
(-18%)
Cap. Flow
-$466M
Cap. Flow
% of AUM
-8.93%
Top 10 Holdings %
Top 10 Hldgs %
39.09%
Holding
140
New
13
Increased
17
Reduced
36
Closed
24
Top Buys
| 1 |
SWTX
SpringWorks Therapeutics
SWTX
|
$161M |
| 2 |
Humana
HUM
|
$46.5M |
| 3 |
BLU
BELLUS Health Inc.
BLU
|
$45.1M |
| 4 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$41.7M |
| 5 |
Ultragenyx Pharmaceutical
RARE
|
$32.3M |
Top Sells
| 1 |
Agilent Technologies
A
|
$66.7M |
| 2 |
Bristol-Myers Squibb
BMY
|
$61M |
| 3 |
Boston Scientific
BSX
|
$60.4M |
| 4 |
Merck
MRK
|
$51.9M |
| 5 |
Illumina
ILMN
|
$51.6M |
Sector Composition
| 1 | Healthcare | 98.11% |
| 2 | Financials | 1.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Exelixis
EXEL
$10.1B
| $69.2M | 1.31% | 3,912,900 | – | – |
|
27
Abbott
ABT
$231B
| $68.8M | 1.31% | 822,400 -115,600 | -12% | -$9.67M |
|
28
PTC Therapeutics
PTCT
$3.92B
| $66.3M | 1.26% | 1,958,900 -130,800 | -6% | -$4.42M |
|
29
Regeneron Pharmaceuticals
REGN
$61.5B
| $63.3M | 1.2% | 228,100 +12,300 | +6% | +$3.41M |
|
30
Sarepta Therapeutics
SRPT
$1.78B
| $63.1M | 1.2% | 837,349 +8,949 | +1% | +$674K |
|
31
Elevance Health
ELV
$71.8B
| $61.1M | 1.16% | 254,600 -107,000 | -30% | -$25.7M |
|
32
DexCom
DXCM
$29.5B
| $57.3M | 1.09% | 384,000 +121,100 | +46% | +$18.1M |
|
33
MeiraGTx Holdings
MGTX
$587M
| $53.4M | 1.01% | 3,349,060 +762,109 | +29% | +$12.2M |
|
|
34
Humana
HUM
$36.5B
| $46.5M | 0.88% | +181,800 | New | +$46.5M |
|
|
PRNB
35
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $45.3M | 0.86% | 1,605,713 | – | – |
|
36
Arvinas
ARVN
$568M
| $45.2M | 0.86% | 2,095,283 -583,527 | -22% | -$12.6M |
|
|
BLU
37
DELISTED
BELLUS Health Inc.
BLU
| $45.1M | 0.86% | +7,025,832 | New | +$45.1M |
|
|
BOLD
38
DELISTED
Audentes Therapeutics, Inc
BOLD
| $44.6M | 0.85% | 1,588,069 -125,000 | -7% | -$3.51M |
|
39
Cigna
CI
$80.3B
| $44.3M | 0.84% | 291,600 +39,000 | +15% | +$5.92M |
|
40
Adicet Bio
ACET
$59.9M
| $42.7M | 0.81% | 4,830,387 | – | – |
|
|
MRTX
41
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $41.7M | 0.79% | +535,143 | New | +$41.7M |
|
|
MYOK
42
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $40.8M | 0.77% | 783,032 -172,268 | -18% | -$8.98M |
|
|
ATNX
43
DELISTED
Athenex, Inc. Common Stock
ATNX
| $40.3M | 0.76% | 3,308,920 -531,210 | -14% | -$6.46M |
|
44
Tandem Diabetes Care
TNDM
$845M
| $39.2M | 0.74% | 664,390 +93,600 | +16% | +$5.52M |
|
|
45
Ultragenyx Pharmaceutical
RARE
$2.89B
| $35.7M | 0.68% | 834,313 +754,706 | +948% | +$32.3M |
|
46
argenx
ARGX
$43.6B
| $35.4M | 0.67% | 310,400 | – | – |
|
|
HARP
47
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $33.4M | 0.63% | 2,446,409 | – | – |
|
48
uniQure
QURE
$896M
| $33M | 0.63% | 839,600 -58,200 | -6% | -$2.29M |
|
49
Crinetics Pharmaceuticals
CRNX
$2.92B
| $30.7M | 0.58% | 2,039,282 | – | – |
|
|
ARQL
50
DELISTED
Arqule Inc
ARQL
| $26.5M | 0.5% | 3,701,273 +2,701,273 | +270% | +$19.4M |
|